{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:08:26Z","timestamp":1779253706768,"version":"3.51.4"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Syst. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is a leading malignancy in men, with global incidence showing geographical variations. In India, PCa burden is increasing, especially in urban areas and for men over 50 years of age. Our collaborative effort with the Cancer Prostate Consortium of India (CAPCI) aims to map the genetic landscape of PCa in India, investigate somatic mosaicism, and assess the utility of low-pass whole-genome sequencing (LP-WGS) in determining PCa pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We performed variant calling using the CONVEX pipeline on whole-exome sequencing (WES) and LP-WGS samples, categorized by tumor grades.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and discussion<\/jats:title>\n                    <jats:p>ClinVar validation of WES variants identified 12 consensus somatic variants mapped to gnomAD, with 11 being pathogenic, likely pathogenic, or variants of uncertain significance (VUS). We also screened 956 germline variants common to at least two of the 49 samples, identifying 88 common variants, including missense and small InDels. Common and unique somatic variants were found in APC, BRAF, ATM, TP53, SMAD4 and CHEK2 genes. Four of these (rs62619935, rs202160435, rs121913343, and rs141568342) are extremely rare (MAF &amp;lt;= 0.001), seven single nucleotide variants (SNVs) are novel, with four being VUS. Pathogenic somatic variants in higher Gleason score samples (4+4 and 4+3) were homozygous, while benign prostatic hyperplasia (BPH) samples with lower Gleason scores were heterozygous, aligning with population stratification. Whereas the rs1042522 variant in the TP53 gene, with a gnomAD MAF of nearly 38%, was a common somatic SNV, we also identified distinct CAG repeat mosaicism associated with PCa risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsysb.2026.1803649","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:34:24Z","timestamp":1779251664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Toward the genetic landscape of prostate cancer in India: insights from whole-exome and low-pass whole-genome sequencing of formalin-fixed paraffin-embedded tumor tissues"],"prefix":"10.3389","volume":"6","author":[{"given":"Soham","family":"Biswas","sequence":"first","affiliation":[{"name":"Department of Biosciences, Manipal University Jaipur","place":["Jaipur, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhargavi","family":"Rajarathinam","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Clappana, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barkha","family":"Khilwani","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Jalendra","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Sharma","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maneesh","family":"Vijavargiya","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajaguru","family":"Aradhya","sequence":"additional","affiliation":[{"name":"Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham","place":["Clappana, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul S.","family":"Ansari","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Shukla","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyaneshwer","family":"Chaubey","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal Kumar","family":"Lohiya","sequence":"additional","affiliation":[{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashanth","family":"Suravajhala","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Manipal University Jaipur","place":["Jaipur, India"]},{"name":"The CA Prostate Consortium of India (CAPCI), Bioclues.org","place":["Hyderabad, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The CA Prostate Consortium of India (CAPCI)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1158\/0008-5472.CAN-05-0399","article-title":"Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer","volume":"65","author":"Alvarado","year":"2005","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.4103\/ijc.ijc_1145_21","article-title":"Expert survey on management of prostate cancer in India: real-World insights into practice patterns","volume":"59","author":"Bakshi","year":"2022","journal-title":"Indian J. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41588-025-02206-1","article-title":"Author correction: mapping genetic diversity with the GenomeIndia project","volume":"57","author":"Bhattacharyya","year":"2025","journal-title":"Nat. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.25259\/JRHM_17_2023","article-title":"Prostate cancer in India: current perspectives and the way forward","volume":"4","author":"Bhargavi","year":"2023","journal-title":"J. Reproductive Healthc. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J. Clinicians"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1055-9965.EPI-12-0495","article-title":"Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer","volume":"21","author":"Breyer","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","article-title":"Genomic hallmarks of localized, non-indolent prostate cancer","volume":"541","author":"Fraser","year":"2017","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.21037\/tcr-2025-232","article-title":"Advances in genomic biomarkers for lethal metastatic castration-resistant prostate cancer","volume":"14","author":"Frimpong","year":"2025","journal-title":"Transl. Cancer Research"},{"key":"B8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3389\/fgene.2020.00874","article-title":"A pilot study on the whole exome sequencing of prostate cancer in the Indian phenotype reveals distinct polymorphisms","volume":"11","author":"Gupta","year":"2020","journal-title":"Front. Genetics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00176","article-title":"Low abundance of circulating tumor DNA in localized prostate cancer","volume":"3","author":"Hennigan","year":"2019","journal-title":"JCO Precision Oncology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"89848","DOI":"10.18632\/oncotarget.21163","article-title":"Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy","volume":"8","author":"Hovelson","year":"2017","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1158\/1078-0432.CCR-22-3394","article-title":"Metastatic prostate cancers with BRCA2 versus ATM mutations exhibit divergent molecular features and clinical outcomes","volume":"29","author":"Hwang","year":"2023","journal-title":"Clin. Cancer Research An Official J. Am. Assoc. Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mgene.2014.07.007","article-title":"Epidemiology of prostate cancer in India","volume":"2","author":"Jain","year":"2014","journal-title":"Meta Gene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/iju.15641","article-title":"Prostate cancer burden in South Asia: a systematic analysis of global burden of disease data (1990-2021)","volume":"32","author":"Kumar","year":"","journal-title":"Int. J. Urology Official J. Jpn. Urological Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.canep.2024.102719","article-title":"Understanding current trends and incidence projections of prostate cancer in India: a comprehensive analysis of national and regional data from the global burden of disease study (1990 -2021)","volume":"94","author":"Kumar","year":"","journal-title":"Cancer Epidemiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"B16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1101\/gr.113084.110","article-title":"SNP detection and genotyping from low-coverage sequencing data on multiple diploid samples","volume":"21","author":"Le","year":"2011","journal-title":"Genome Research"},{"key":"B17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N. Engl. Journal Medicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2527805","DOI":"10.1001\/jamanetworkopen.2025.27805","article-title":"Cancer incidence and mortality across 43 cancer registries in India","volume":"8","author":"Mathur","year":"2025","journal-title":"JAMA Network Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10552-015-0644-y","article-title":"Racial\/ethnic differences in lifestyle-related factors and prostate cancer risk: the multiethnic cohort study","volume":"26","author":"Park","year":"2015","journal-title":"Cancer Causes and Control CCC"},{"key":"B20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/ijms26010318","article-title":"The emerging predictive and prognostic role of aggressive-variant-associated tumor suppressor genes across prostate cancer stages","volume":"26","author":"Pedrani","year":"2025","journal-title":"Int. J. Molecular Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","article-title":"BEDTools: a flexible suite of utilities for comparing genomic features","volume":"26","author":"Quinlan","year":"2010","journal-title":"Bioinformatics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/2023.10.07.561328","article-title":"CONVEX: consensus variant pipeline for exome analysis","volume":"10","author":"Raju","year":"2023","journal-title":"bioRxiv"},{"key":"B25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jmoldx.2024.01.014","article-title":"Assay validation of cell-free DNA shallow whole-genome sequencing to determine tumor fraction in advanced cancers","volume":"26","author":"Rickles-Young","year":"2024","journal-title":"J. Molecular Diagnostics JMD"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/iju.iju_27_24","article-title":"Descriptive epidemiology of prostate cancer in India, 2012-2019: insights from the national cancer registry programme","volume":"40","author":"Sankarapillai","year":"2024","journal-title":"Indian J. Urology IJU J. Urological Soc. India"},{"key":"B28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/diseases11020072","article-title":"Towards understanding the key signature pathways associated from differentially expressed gene analysis in an Indian prostate cancer cohort","volume":"11","author":"Shukla","year":"2023","journal-title":"Diseases"},{"key":"B30","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5144\/0256-4947.2004.21","article-title":"Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia","volume":"24","author":"Tayeb","year":"2004","journal-title":"Ann. Saudi Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief. Bioinform"},{"key":"B34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41588-018-0086-z","article-title":"Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets","volume":"50","author":"Wedge","year":"2018","journal-title":"Nat. Genetics"}],"container-title":["Frontiers in Systems Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2026.1803649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:34:37Z","timestamp":1779251677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2026.1803649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":34,"alternative-id":["10.3389\/fsysb.2026.1803649"],"URL":"https:\/\/doi.org\/10.3389\/fsysb.2026.1803649","relation":{},"ISSN":["2674-0702"],"issn-type":[{"value":"2674-0702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1803649"}}